Gary B. Schneider, Ph.D., Associate Vice Provost for Research and Professor of Molecular Medicine at the University of Massachusetts Medical School, has been named Chief of Research at New England Baptist Hospital.
Schneider joins NEBH from the University of Massachusetts Medical School and the Office of Research Integration for the UMass Center for Clinical and Translational Research, where he served as the Director of the Office of Research Integration for the UMass Center for Clinical and Translational Research. His primary research interests are in bone cell biology.
“Gary Schneider is an outstanding researcher and mentor,” said NEBH President and CEO, Trish Hannon. “His leadership and expertise will allow the Baptist to continue to be recognized as one of the top specialty institutions in the country.”
Dr. Schneider, in collaboration with the medical staff will articulate a new vision for NEBH research and will ensure that the research focus is closely connected to the mission, vision and future of NEBH. He will serve as the research thought leader for the hospital and will be a valuable resource for clinicians and staff. Dr. Schneider will also provide clinical and analytic oversight to the Joint Registry, and will work with internal and external investigators to publish manuscripts using Registry data. Dr. Schneider will oversee the annual fellows’ research training program.
“New England Baptist Hospital is the premier orthopedic specialty hospital in the region, with a superb, dedicated staff. In surgery and patient care, New England Baptist Hospital is second to none. My vision for the future of the Baptist is for unparalleled expansion of research and teaching endeavors to meet that same level of excellence. I am excited by the enthusiasm of all at New England Baptist Hospital to advance and excel,” said Schneider.
Schneider received a Bachelor of Science degree in Zoology from the University of Wisconsin-Madison, and his Ph.D in Biochemistry from the cooperative five-college program (Amherst, Hampshire, Mt. Holyoke, Smith College, and the UMass-Amherst). Following graduate school, he spent eight years at UMass Medical School rising to the level of Associate Professor in Anatomy. He has held several positions including: Director of Research for the Western Pennsylvania Research Institute, Professor of Cell Biology and Anatomy at Rosalind Franklin University of Medicine and Science/The Chicago Medical School, Associate Dean for Basic Medical Sciences and Associate Dean for Research at Northeast Ohio Medical University, Senior Associate Dean for Research at Weill Cornell Medical College at the branch campus in Doha, Qatar, Professor of Cell and Developmental Biology at Weill Medical College of Cornell University in New York and the most recent Professor of Molecular Medicine, and Associate Vice Provost for Research, University of Massachusetts Medical School.
Schneider has published more than 58 peer-reviewed articles, and is currently a consultant reviewer for the Journal of Bone and Mineral Research. He has given many scientific presentations both nationally and internationally and is a member of numerous professional societies, including the American Association for the Advancement of Science, American Society for Bone and Mineral Research, American Society for Cell Biology and International Bone and Mineral Society.
Schneider’s previous faculty appointments have been in departments of cell biology and orthopedic surgery. For over 25 years, he was continuously funded by the NIH to conduct research programs involving stem cell transplantation, drug discovery and gene therapy as potential treatments for a number of bone diseases and skeletal disorders. The majority of Dr. Schneider’s career has been directed to translational research. An inventor, he holds multiple patents related to musculoskeletal diseases and has worked with a wide range of businesses on the development of new technologies in the fields of human stem cells, drug discovery and medical devices. He has served on a number of National Institutes of Health study sections and special emphasis panels as well as National Research Council and National Science Foundation review groups. Most recently, he has directed his efforts toward research administration.
Schneider served as the Associate Dean for Basic Medical Sciences and Associate Dean for Research at the Northeastern Ohio Universities College of Medicine for eight years, where he oversaw all research operations. Prior to the University of Massachusetts Medical School, he served as the Senior Associate Dean for Research at the Weill Cornell College of Medicine in Qatar, where he developed and implemented the biomedical research strategy and infrastructure for the branch campus in the Persian Gulf. During that time, he also served as Professor of Cell and Developmental Biology at the Weill Medical College of Cornell University in New York City.
“Dr. Schneider embodies all of the characteristics required to lead our Research Department into the next era. He is a leader and a dedicated teacher and researcher,” said John Richmond, MD, Chair, Department of Orthopedics.
About New England Baptist Hospital
New England Baptist Hospital is a premier orthopedic center of excellence, providing the highest quality medical and surgical care. More complex orthopedic procedures are performed at New England Baptist than at any other hospital in Massachusetts, and the hospital is a national leader in quality and clinical outcomes. The site of one of the first artificial hip replacements in the country, NEBH has been recognized by several national entities as being among the best hospitals in the country. The hospital continues to lead the way in new methods to diagnose and treat all forms of musculoskeletal disease and related disorders.
New England Baptist’s commitment to providing legendary service to patients and visitors has earned a consistent ranking in the top 1%. NEBH is the only inpatient hospital in Massachusetts to receive the prestigious Summit Award for inpatient satisfaction, four years in a row.
The Hospital is a teaching affiliate of Tufts University School of Medicine and conducts teaching programs in collaboration with the Harvard School of Public Health and the Harvard School of Medicine.